CGRP receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups

Details for Australian Patent Application No. 2008239754 (hide)

Owner Merck & Co., Inc.

Inventors Selnick, Harold G.; McWherter, Melody; Schirripa, Kathy; Kim, June; Wood, Michael R.

Agent Spruson & Ferguson

Pub. Number AU-A-2008239754

PCT Pub. Number WO2008/127584

Priority 60/922,929 11.04.07 US

Filing date 7 April 2008

Wipo publication date 23 October 2008

International Classifications

A61K 31/497 (2006.01)

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/127584 Priority application(s): WO2008/127584

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008239755-Substituted furo[2,3-b]pyridine derivatives as Cannabinoid-1 receptor modulators

2008239737-Novel nutritional food products for improved digestion and intestinal absorption